Tumor lysis syndrome differential diagnosis

Revision as of 21:05, 27 February 2019 by Ahmed Younes (talk | contribs)
Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]

Overview

Tumor lysis syndrome must be differentiated from other diseases that cause hyperuricemia, hyperkalemia, and hyperphosphatemia, such as acute kidney injury. The common conditions are hereditary hyperuricemia, Insulin resistance, Hypertension, Obesity, Gout, Alcoholism and renal insufficiency. Patients taking ACE inhibitor, NSAIDs and Antibiotics such as trimethoprim are more prone to hyperkalemia. Hyperphosphatemia is usually seen in Acute kidney injury, Hypoparathyroidism, vitamin D supplementation and also in sarcoidos.

Differentiating tumor lysis syndrome from other Diseases

Tumor lysis syndrome must be differentiated from other diseases that cause electrolytes disturbance.[1]

  • Transcellular phosphate shifts:

References

  1. Wilson FP, Berns JS (2014). "Tumor lysis syndrome: new challenges and recent advances". Adv Chronic Kidney Dis. 21 (1): 18–26. doi:10.1053/j.ackd.2013.07.001. PMC 4017246. PMID 24359983.
  2. 2.0 2.1 2.2 Wikipedia.https://en.wikipedia.org/wiki/Hyperuricemia

Template:WH Template:WS